Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12209041 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)
Condition: Osteoarthritis
Interventions: Drug: MK0663, etoricoxib / Duration of Treatment: Part I (6 weeks), Part II (8 weeks);   Drug: Placebo;Diclofenac 50mg(tid)/Duration of Treatment: Part I (Placebo) 6 weeks;Part II (Diclofenac) 8 weeks

Indicates status has not been verified in more than two years